Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Letter

Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation

Authors

M K de Vries PubMed articles Google scholar articles
G J Wolbink PubMed articles Google scholar articles
S O Stapel PubMed articles Google scholar articles
E R de Groot PubMed articles Google scholar articles
B A C Dijkmans PubMed articles Google scholar articles
L A Aarden PubMed articles Google scholar articles
I E van der Horst-Bruinsma PubMed articles Google scholar articles

Correspondence to:
Dr M K de Vries
Department of Rheumatology, VU University Medical Centre, Room 4A-42, PO Box 7057, 1007 MB Amsterdam, The Netherlands; mk.devries{at}vumc.nl

Citation

de Vries MK, Wolbink GJ, Stapel SO, et al

Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation

Annals of the Rheumatic Diseases 2007;66:133-134.

Publication history

Accepted June 5, 2006
First published December 18, 2006.

Online issue publication

April 13, 2016

Copyright information

Copyright 2007 by Annals of the Rheumatic Diseases